AstraZeneca vaccine blood clot risk ‘very rare’ — EU regulator

AstraZeneca

The EU’s medicines regulator said Wednesday that blood clots should be listed as a rare side effect of the AstraZeneca jab but the benefits continue to outweigh risks, as several countries battle fresh virus surges amid vaccine shortfalls.

A number of nations have suspended the use of AstraZeneca’s vaccine for younger populations after it was earlier banned outright in several places…

Report

Avatar
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments